Literature DB >> 34246346

Benzodiazepines for the long-term treatment of anxiety disorders? - Authors' reply.

Brenda W J H Penninx1, Daniel S Pine2, Emily A Holmes3, Andreas Reif4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34246346      PMCID: PMC9092619          DOI: 10.1016/S0140-6736(21)00931-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.

Authors:  April Slee; Irwin Nazareth; Paulina Bondaronek; Yifeng Liu; Zhihang Cheng; Nick Freemantle
Journal:  Lancet       Date:  2019-01-31       Impact factor: 79.321

2.  Benzodiazepines versus placebo for panic disorder in adults.

Authors:  Johanna Breilmann; Francesca Girlanda; Giuseppe Guaiana; Corrado Barbui; Andrea Cipriani; Mariasole Castellazzi; Irene Bighelli; Simon Jc Davies; Toshi A Furukawa; Markus Koesters
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28

Review 3.  Anxiety disorders.

Authors:  Brenda Wjh Penninx; Daniel S Pine; Emily A Holmes; Andreas Reif
Journal:  Lancet       Date:  2021-02-11       Impact factor: 202.731

  3 in total
  1 in total

1.  Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.

Authors:  Gui Xiao; Qingnan He; Li Liu; Tingting Zhang; Mengjia Zhou; Xingxing Li; Yijun Chen; Yanyi Chen; Chunxiang Qin
Journal:  J Transl Med       Date:  2022-10-20       Impact factor: 8.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.